Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

Mark Gurnell, Christian Domingo, Klaus F Rabe, Andrew Menzies-Gow, David Price, Guy Brusselle, Michael E Wechsler, Changming Xia, Michel Djandji, Rebecca Gall, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz, Shahid Siddiqui

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusAccepted/In press - 8 Aug 2022
EventWorld Allergy Congress 2022 - Hilton Bomonti Istanbul Hotel & Conference Center, Istanbul, Turkey
Duration: 13 Oct 202215 Oct 2022


ConferenceWorld Allergy Congress 2022
Abbreviated titleWAC 2022 Istanbul
Internet address

Cite this